Buy Alert: November 5, 2013

| November 5, 2013

Buy Alert:  November 5, 2013


Trade Details

Buy Merck (MRK) December $45 Calls for $1.18 or better



Our first of two trades today, pharmaceutical giant MRK has been underperforming the broader market.  The company has at least one promising vaccine on the way (in Phase III) and several others farther down the pipeline.  Yet, the stock sold off after weaker than expected profits from diabetes drug sales.

As usual, it’s a temporary situation for an enormous drug manufacturer like Merck.  And now, the share price has dropped below all three of its major moving averages.

MRK options are cheap, so we’re going to buy the at-the-money calls and plan for a move back towards the 50-day moving average.


Recent Activity



Category: OTW Buy Alerts